As of late November 2024, the US Food & Drug Administration had recorded 46 voluntary drug recalls in the United States during the year, down slightly from previous years – an indicatio
Even now, after a decade of run-up, pharma’s readiness to implement and harness ISO IDMP standards still varies wildly, as does companies’ relative maturity in supporting
In his recent speech on the need for NHS reform, the prime minister announced that support for preventative care in communities would be at the heart of the Government’s approach.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.